ALLARITY THERAPEUTICS INC (ALLR)
US0167444019 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 166.00K | 2.03M | 19.56M | 300.00K | 1.52M | |||
| Marketable Securities | 56.00K | 50.00K | 50.00K | 70.00K | 60.00K | |||
| Receivables | 946.00K | 870.00K | 1.35M | 1.07M | 1.33M | |||
| Other Current Assets | 803.00K | 2.02M | 110.00K | 270.00K | 430.00K | |||
| Total Current Assets | 1.97M | 4.97M | 21.05M | 1.72M | 3.34M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.00K | 30.00K | 90.00K | 350.00K | 440.00K | |||
| Investments And Advances | N/A | 0.00 | 350.00K | 850.00K | 140.00K | |||
| Intangibles | 9.87M | 9.55M | 28.14M | 30.49M | 27.69M | |||
| Total Non-Current Assets | 9.89M | 9.57M | 28.58M | 31.68M | 28.27M | |||
| TOTAL ASSETS | 11.86M | 14.54M | 49.63M | 33.40M | 31.61M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 2.64M | 0.00 | 1.41M | 540.00K | |||
| Current Portion Of LT Debt. | 1.30M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 1.31M | 1.91M | 8.69M | 1.95M | 1.96M | |||
| Accounts Payable | 8.42M | 6.25M | 700.00K | 2.12M | 2.18M | |||
| Other Current Liabilities | 3.14M | 420.00K | 11.33M | 60.00K | 40.00K | |||
| Total Current Liabilities | 14.17M | 11.22M | 20.72M | 5.53M | 4.72M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 1.08M | 980.00K | 880.00K | 0.00 | |||
| Deferred Taxes/Income | 446.00K | 350.00K | 1.96M | 2.14M | 1.85M | |||
| Other Non-Current Liabilities | N/A | 0.00 | 7.19M | 420.00K | 4.13M | |||
| Total Non-Current Liabilities | 446.00K | 1.43M | 10.13M | 3.43M | 8.80M | |||
| TOTAL LIABILITIES | 14.61M | 12.65M | 30.85M | 8.96M | 13.52M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -94.45M | -82.55M | -66.49M | -39.84M | -32.37M | |||
| Additional Paid In Capital | 90.37M | 83.16M | 84.43M | 62.48M | 50.62M | |||
| Minority Interest | N/A | N/A | 0.00 | 20.00K | 2.91M | |||
| Common Shares | 1.74M | 2.00M | 1.44M | 430.00K | 920.00K | |||
| Other Shareholders' Equity | -411.59K | -720.00K | -600.00K | 1.38M | -1.09M | |||
| Shares Outstanding | 294.35K | 10.00K | 10.00K | 10.00K | 10.00K | |||
| Tangible Book Value per Share | -48.80 | -966.00 | -999.00 | -605.00 | -960.00 | |||
| Total Shareholders' Equity | -2.75M | 1.89M | 18.78M | 24.44M | 18.09M | |||
| TOTAL LIABILITIES AND EQUITY | 11.86M | 14.54M | 49.63M | 33.40M | 31.61M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 1.97 | 0.05 | 0.09 | N/A | |||
| Current Ratio | 0.14 | 0.44 | 1.02 | 0.31 | 0.71 | |||
| Return On Assets (ROA) | -172.11% | -144.77% | -53.70% | -19.76% | -45.27% | |||
| Return On Equity (ROE) | N/A | -1113.76% | -141.91% | -27.00% | -79.10% | |||
All data in USD